Skip to main content
Fig. 1 | Reproductive Biology and Endocrinology

Fig. 1

From: Improved clinical outcomes after non-invasive oocyte selection and Day 3 eSET in ICSI patients

Fig. 1

Patient flow. *Patients eligible for the cumulus cell test study: Not recruited for any other study, stimulated with HP-hMG in a GnRH antagonist protocol from Day 6, fresh eSET, scheduled for ICSI, up to 39 years old, with at least 2 transferable embryos on Day 3, with follow up data (up to clinical pregnancy) Excluded: PGD/PGS, TESE, FNA, PCOS, known poor ovarian response. **: A weighted generalized linear model was used with weighted averages to stratify the populations for age and number of transferable embryos on Day 3. *** to prevent potential confounding factors 113 exact matched controls nearest in time to the experimental case were retained for the Kaplan-Meier analysis

Back to article page
\